Target intelligence / Profile preview

Small airway of the lung

Molecular classification
Other (anatomic structure; not a molecule or receptor)
01

Overview

The small airways of the lung include the terminal and respiratory bronchioles and, in some definitions, the alveolar ducts. These structures have diameters generally less than 2 mm and lack supporting cartilage and submucosal glands[3][5]. Their main functions are conduction of air to the alveoli (where gas exchange occurs), humidification and cleaning via mucociliary clearance, and regulation of airway resistance through smooth muscle contraction[1][3][5]. Small airway dysfunction is implicated in several pulmonary diseases, including asthma, chronic obstructive pulmonary disease (COPD), and bronchiolitis, and is a key site of disease pathology and therapeutic intervention. Drugs such as inhaled corticosteroids, bronchodilators, and mucolytics may be optimized to reach the small airways, although the small airways themselves are not molecular targets but anatomical locations for the drug's site of action.

Other names
Small airwaysPeripheral airwaysDistal airwaysBronchioles (includes terminal and respiratory bronchioles)
02

Mechanism of action

Local anti-inflammatory action (corticosteroids); Bronchodilation (β2-agonists, anticholinergics); Mucolytic effects (expectorants, though less direct)

03

Biological functions

Conduction of air to and from the gas exchange areasMucociliary clearanceRegulation of airway resistanceIn some parts, limited innate immune defense
04

Disease associations

Asthma (site of obstruction/inflammation)Chronic obstructive pulmonary disease (COPD; airway remodeling, inflammation)Bronchiolitis (inflammation/infection)Cystic fibrosis (site of mucus plugging)
05

Safety considerations

Deposition of inhaled drugs may be variableRisk of local irritation, bronchospasmSmall airway disease often progresses insidiously and may not be detected early by standard spirometric tests
06

Interacting drugs

Inhaled corticosteroids

2 more in the full profile.

07

Biomarkers

Imaging (high-resolution CT findings, air trapping)Pulmonary function tests (e.g. FEF25-75, measuring flow in small airways)Exhaled nitric oxide (in inflammation)

Beyond the preview

Go deeper on Small airway of the lung.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small airway of the lung.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call